Results of a recent study suggest that the combination of two common diabetes drugs could reduce mortality and the risk of adverse cardiovascular events.
A recent study examined the risk of blindness, kidney failure, amputation, hyperglycemia, and hypoglycemia associated with the use of hypoglycemic agents, including glitazones, gliptins, metformin, and...